MedPath

Feasible study of the effect of irbesartan on psoriasis

Not Applicable
Conditions
psoriasis
Registration Number
JPRN-UMIN000025949
Lead Sponsor
Department of Dermatology, Kochi Medical School, Kochi University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Minors or adults of imcomplete judgement

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of PASI three months after the start of Irbesartan
Secondary Outcome Measures
NameTimeMethod
Assessment of PDI three months after the start of Irbesartan
© Copyright 2025. All Rights Reserved by MedPath